ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

IDH Immunodiagnostic Systems Holdings Plc

378.00
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immunodiagnostic Systems Holdings Plc LSE:IDH London Ordinary Share GB00B01YZ052 ORD 2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 378.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Immunodiagnostic Systems Hldgs PLC Result of AGM (3431M)

27/07/2017 3:45pm

UK Regulatory


Immunodiagnostic Systems (LSE:IDH)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Immunodiagnostic Systems Charts.

TIDMIDH

RNS Number : 3431M

Immunodiagnostic Systems Hldgs PLC

27 July 2017

Results of AGM

Immunodiagnostic Systems Holdings PLC

27 July 2017

Immunodiagnostic Systems Holdings plc

Results of AGM

Immunodiagnostic Systems Holdings PLC ("the Company"), a specialist producer of manual and automated diagnostic testing kits and instruments for the clinical market, announces the results of its Annual General Meeting (the "Meeting") that was held at 2pm today.

Trading Update

At the meeting the Chairman, Dr Burkhard Wittek, provided a business update. A copy of the statement has been made available on the Company's website.

Voting Results

All resolutions put to the Meeting were decided on a show of hands and all were duly passed.

For information, details of the proxy voting are shown below:

 
 Resolution                          Votes For    Votes For      Votes Against   Votes Withheld 
                                                   (as % of       (as % of 
                                                   votes cast)    votes cast) 
----------------------------------  -----------  -------------  --------------  --------------- 
      1. To receive the 
       accounts for the 
       year ended 31 March 
       2017 together with 
       the report of the 
       Directors and of 
       the Auditor thereon.          14,124,207   100%           0.00%           0 
----------------------------------  -----------  -------------  --------------  --------------- 
      2. To declare a 
       final dividend 
       for the year ended 
       31 March 2017.                14,124,207   100%           0.00%           0 
----------------------------------  -----------  -------------  --------------  --------------- 
      3. To elect as 
       a director of the 
       Company Mr Regis 
       Jacques Duval.                14,118,287   100%           0.00%           5,300 
----------------------------------  -----------  -------------  --------------  --------------- 
      4. To re-appoint 
       Ernst & Young LLP 
       as Auditor of the 
       Company.                      14,124,207   100%           0.00%           0 
----------------------------------  -----------  -------------  --------------  --------------- 
      5. To authorize 
       the Directors of 
       the Company to 
       determine the remuneration 
       of the Auditor 
       of the Company.               14,124,207   100%           0.00%           0 
----------------------------------  -----------  -------------  --------------  --------------- 
      6. To approve the 
       Directors' Remuneration 
       Report for the 
       financial year 
       ended 31 March 
       2017.                         14,118,237   99.96%         0.04%           50 
----------------------------------  -----------  -------------  --------------  --------------- 
      7. To authorise 
       the Directors to 
       allot relevant 
       securities.                   14,124,207   100%           0.00%           0 
----------------------------------  -----------  -------------  --------------  --------------- 
      8. To authorise 
       the disapplication 
       of pre-emption 
       rights in accordance 
       with section 570 
       of the Companies 
       Act 2006.                     14,109,207   99.89%         0.11%           0 
----------------------------------  -----------  -------------  --------------  --------------- 
      9. To authorise 
       the Directors to 
       make market purchases.        14,123,607   100%           0.00%           0 
----------------------------------  -----------  -------------  --------------  --------------- 
 

The full text of each of the resolutions is set out in the notice of Annual General Meeting, copies of which are available on the IDS website (www.idsplc.com).

For further information:

   Immunodiagnostic Systems Holdings plc                          Tel : +44 (0)191 5190660 

Paul Martin, Group Finance Director

Peel Hunt LLP Tel : +44 (0)207 418 8900

James Steel

Oliver Jackson

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGSELFLWFWSELW

(END) Dow Jones Newswires

July 27, 2017 10:45 ET (14:45 GMT)

1 Year Immunodiagnostic Systems Chart

1 Year Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart

1 Month Immunodiagnostic Systems Chart

Your Recent History

Delayed Upgrade Clock